1. Introduction {#sec0005}
===============

Necrotizing pancreatitis develops in approximately 20% of patients with acute pancreatitis, and it is associated with mortality rates of 11--39% [@bib0005]. Hemorrhagic complications account for approximately 50% of deaths with a higher risk of bleeding in the setting of pancreatic necrosis. Open debridement of infected necrotic pancreatic tissue has been the traditional treatment strategy in patients with infected pancreatic and peripancreatic tissue, but this strategy entails significant morbidity [@bib0010; @bib0015]. More recently, as an alternative to open necrosectomy, percutaneous drainage followed by minimally invasive video-assisted retroperitoneal debridement (VARD) via the "step up approach" has been shown to reduce mortality and rates of secondary complications such as hemorrhage [@bib0020].

Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a technique that has been shown to provide central vascular control to support proximal aortic pressure and minimize hemorrhage in a wide variety of clinic settings including trauma, vascular populations and for patients undergoing pelvic surgery [@bib0025; @bib0030]. As an alternative to conventional resuscitative thoracotomy, REBOA has been shown to preserve myocardial and cerebral tissue perfusion in a less invasive fashion [@bib0025]. The procedure involves obtaining arterial access through the common femoral artery, inserting a large vascular sheath through which a balloon catheter can then be inflated in the appropriate section of the aorta to occlude blood flow [@bib0025] For the purposes of endovascular control, the aorta is divided into three zones of bleeding. Zone 1 is in the descending thoracic aorta for abdominal hemorrhage, Zone 3 is below the renal arteries but above the aortic bifurcation for pelvic hemorrhage, and Zone 2 in the mid abdominal aorta with critical visceral branches is a proposed no-occlusion zone [@bib0025].

The use of REBOA in emergency general surgery patients has not been extensively described in the literature. We present a case where REBOA was used to prevent ongoing hemorrhage during VARD for the treatment of necrotizing pancreatitis.

2. Case presentation {#sec0010}
====================

The patient is a 44-year old man who presented with gallstone pancreatitis. This progressed to severe, infected necrotizing pancreatitis complicated by respiratory failure and acute kidney injury. During his index admission, he was managed via the step up approach as described by Van Santvoort et al., \[4\]. Peripancreatic collections were drained by percutaneous left flank retroperitoneal catheters in the anterior and mid axillary lines, and after interval stabilization he returned for an elective VARD procedure and simultaneous cholecystectomy. Preoperative computed tomography demonstrated the drains to be within the lesser sac beside his pancreatic collections, which had gas foci indicative of ongoing infection.

Under general anesthesia, the drain sites were accessed for placement of 5--10 mm trocars. A working thoracoscope was introduced into the retroperitoneum, where significant scarring, inflammation and necrosis were noted. Sharp pancreatic debridement with toothed forceps under direct visualization was initiated, but during the course of debridement, brisk arterial bleeding was encountered. The retroperitoneum was packed with hemostatic agents, and the patient was taken emergently to the interventional radiology suite for angioembolization of bleeding intercostal arteries. The patient was taken to the intensive care unit post-operatively for hemodynamic monitoring and resuscitation.

Forty-eight hours later, the patient returned to the operating room for removal of retroperitoneal packing and completion VARD. However, after removal of several large segments of necrotic debris, brisk arterial bleeding from what appeared to be the splenic capsule was encountered. The procedure was converted to a midline exploratory laparotomy. Upon entry into the peritoneum, dense vascularized adhesions were encountered that involved the entire left upper quadrant which prevented safe dissection of the splenic hilum. The patient developed hemodynamic instability with a mean arterial pressure below 50 mm Hg despite four quadrant packing. At this juncture, supra celiac clamping of the aorta appeared to be impossible due to the degree of vascular adhesions in this area and the decision was made to place a REBOA to gain vascular control.

The right groin was explored to expose and control the patient's right common femoral artery. Via open Seldinger technique [@bib0035], the vessel was accessed with a 20 Fr hollow bore needle and a 0.035 guidewire was inserted. Next a 5 Fr sheath was inserted, through which a 0.035 Bentson wire (Cook Incorporated, Bloomington, IN) was advanced into the thoracic aorta. The 5Fr sheath was then removed and upsized to a 14Fr sheath. Via this sheath, a 32 mm CODA balloon catheter (Cook Incorporated, Bloomington, IN) (See [Picture 1](#fig0005){ref-type="fig"}) was inserted and deployed in the descending thoracic aorta. Landmarks as well as Intraoperative fluoroscopy confirmed wire and balloon placement.

Following balloon inflation, the patient's hemodynamics immediately improved and stabilized, enabling adequate resuscitation by anesthesia and further retroperitoneal packing. For definitive hemostasis, the REBOA balloon was slowly deflated, and angioembolization of a left intercostal artery was performed in the interventional radiology suite. He was subsequently stable without signs of bleeding, and the REBOA was removed and the femoral access site closed. No procedural complications occurred. Two days later the packing was removed, and completion necrosectomy and cholecystectomy were performed. After an 18-day hospital stay, the patient was discharged home and is doing well without gastrointestinal or vascular complaints.

3. Discussion {#sec0015}
=============

The use of REBOA in non-trauma general surgery patients is an option for those in hemorrhagic shock whom conventional aortic cross-clamping or supra-celiac aortic exposure is either not possible or exceedingly dangerous as we described here. Placement of a REBOA can be performed via simple femoral artery cut-down with catheter and balloon confirmation via external landmarks and fluoroscopy. REBOA allows for adequate resuscitation and can be used as a bridge to definitive therapy in a range of surgical subspecialties with minimal morbidity and complications. (See [Table 1](#tbl0005){ref-type="table"})

Balloon occlusion of the aorta to tamponade bleeding was first described during the Korean War in the 1950's on three wounded soldiers. Two soldiers were temporized long enough for exploratory laparotomy; however, all three soldiers eventually succumbed from their injuries [@bib0040]. In 1986, Low et al. described the largest series to date of twenty three patients with life-threatening hemorrhagic shock from traumatic injuries and ruptured abdominal aortic aneurysms in which a similar balloon aortic occlusion device was utilized [@bib0045]. He noted a marked improvement in blood pressure in all of the patients, however only two of fifteen trauma victims and four aneurysm patients in whom the balloon was used were long-term survivors.

Electively, REBOA has been used to limit blood loss during sacral tumor resection and in other pelvic surgery [@bib0050; @bib0055]. In this setting, morbidity and mortality from aortic occlusion is infrequent, and primarily consists of access site complications or distal embolization, although aortic rupture has been reported [@bib0060].

4. Conclusions {#sec0020}
==============

Recently, there has been a resurgence of this technique utilized in trauma populations [@bib0030; @bib0065; @bib0070; @bib0075]. These series have consistently shown that aortic balloon occlusion provides effective central vascular control, and, in the setting of hemorrhage, improved hemodynamics and cessation of active bleeding. In the series reported by, Brenner et al., six patients from two Level I trauma centers underwent REBOA for refractory hemorrhagic shock secondary to blunt and penetrating traumatic injuries [@bib0030]. After balloon occlusion, patients had an average increase in blood pressure of 55 mm Hg and were able to be transported to either interventional radiology or the operating room for definitive management of their traumatic injuries. Four of the patients survived without long-term complications; two patients unfortunately expired within days due to neurological complications of their initial injuries.

The major obstacles to widespread REBOA utilization include access to the device and appropriate education of the technique. In the modern case series by Brenner et al., all trauma surgeons had either training in a formal training course or basic endovascular experience during surgical training [@bib0030; @bib0080] While these training courses are only currently available at a handful of academic medical centers, it is feasible to incorporate and emphasize skills learned within this course more broadly in general surgical training. Finally, the risks associated with insertion of wires, sheaths, and catheters into the arterial system, as well as the risk of visceral and spinal cord ischemia due to aortic occlusion mandate that the use of this technique be utilized in only appropriate clinical scenarios.
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![CODA 32 mm balloon mounted on 100 cm flexible 10 Fr catheter (Cook Incorporated, Bloomington, IN). Introduced via 14 Fr sheath.](pl1){#fig0005}

  Clinical use                Total patients, *n*   Mortality, *n* (%)   Complications, *n* (%)   References
  --------------------------- --------------------- -------------------- ------------------------ ----------------------------------------------------------------------------------
  Elective surgery            151                   3 (2%)               9 (6%)                   [@bib0050; @bib0055; @bib0085]
  Trauma surgery              82                    5 (6%)               2 (2%)                   [@bib0030; @bib0040; @bib0045; @bib0065; @bib0070; @bib0075; @bib0090; @bib0095]
  Emergency general surgery   1                     0                    0                        [@bib0100]

Morbidity and mortality associated with REBOA use.
